Liposomes as Immunoadjuvants for Saccharide Antigens

References

• Tang P. W., Gool H. C., Hardy M., Lee Y. C., Feizi T. Novel approach to the study of the antigenicities and receptor functions of carbohydrate chains of glycoproteins. Biochem. Biophys. Res. Comm. 1985; 132: 474
   PubMedGoogle Scholar
• Takada M., Yuzuriha T., Katayama K, Iwamoto K., Sunamoto J. Increased lung uptake of liposomes coated with polysaccharides. Biochem. Biophys. Acta 1984; 802: 237
   PubMed Web of Science ®Google Scholar
• Naoi M., Yagi K. Effect of glycolipids contained in liposomes on the incorporation of beta-galactosidase into specific organs. Biochem. Int. J. 1984; 9: 267
   PubMedGoogle Scholar
• Das P. K., Murray G. J., Zirzow G. C., Brady R. O., Barranger J. A. Lectin-specific targeting of beta-glucocerebrosidase to different liver cells via glycosylated liposomes. Biochem. Med. 1985; 33: 124
   PubMed Web of Science ®Google Scholar
• Latif N., Bachhawat B. K. The effect of surface sugars on liposomes in immunopotentiation. Immunol. Lett. 1984; 8: 75
   PubMedGoogle Scholar
• Hoekstra D., Duzgunes N., Wildschut J. Agglutination and fusion and globoside GL-4 containing phospholipid vesicles by lectins and calcium ions. Biochemistry 1985; 24: 565
   PubMedGoogle Scholar
• Yasuda T., Kanegasaki S., Tsumita T., Tadakuma T., Ikewaki N., Homma J. Y., Inage M., Kusumoto S., Shiba T. Further study of biological activities of chemically synthesized analogues of lipid A in artificial membrane vesicles. Eur. J. Biochem. 1984; 140: 245
   PubMedGoogle Scholar
• Tang P. W., Feizi T. Neoglycolipid microimmunoassays applied to the oligosaccharides of human milk galactosyltransferase detect blood-group related antigens on both O- and N-linked chains. Carbohydrate Research 1987; 161: 133
   PubMedGoogle Scholar
• Strauss G., Schurtenberger P., Hauser H. The interaction of saccharides with lipid bilayer vesicles: stabilization during freeze-thawing and freeze-drying. Biochem. Biophys. Acta 1986; 858: 169
   PubMed Web of Science ®Google Scholar
• Fabrie C. H., De Kruijff B., De Gier J. Protection by sugars against phase-transition-induced leak in hydrated dimyristoylphosphatidylcholine liposomes. Biochem. Biophys. Acta 1990; 1024: 380
   PubMedGoogle Scholar
• Van Houte A. J., Snippe H., Willers J. M. N. Characterization of immunogenic properties of haptenated liposomal model membranes in mice. I. Thymus independence of the antigen. Immunology 1979; 37: 505
   PubMedGoogle Scholar
• Van Houte A. J., Snippe H., Peulen G. T. M., Willers J. M. N. a. Characterization of immunogenic properties of haptenated liposomal model membranes in mice. II Induction of delayed-type hypersensitivity. Immunology 1981; 42: 165
   PubMedGoogle Scholar
• Van Houte A. J., Snippe H., Peulen G. T. M., Willers J. M. N. b. Characterization of immunogenic properties of haptenated liposomal model membranes in mice. III. Specificity in delayed-type hypersensitivity and antibody formation. Immunology 1981; 42: 233
   PubMedGoogle Scholar
• Van Houte A. J., Snippe H., Willers J. M. N. Characterization of immunogenic properties of haptenated liposomal model membranes in mice. IV. Introduction of IgM memory. Immunology 1981; 43: 627
   PubMedGoogle Scholar
• Van Houte A. J., Snippe H., Schmitz M. G. J., Willers J. M. N. Characterization of immunogenic properties of haptenated liposomal model membranes in mice. V. Effect of membrane composition on humoral and cellular immunogenicty. Immunology 1981; 44: 561
   PubMed Web of Science ®Google Scholar
• Snippe H., Houte A. J., vanJanssen A, Willers J. M. N., Lizzo E. F., Merchant B. Characterization of immunogenic properties of haptenated liposomal model membranesin mice. VII. Synergistic responses to haptenated liposomes and haptenated thymus-dependent antigens in CBA/N mice. Immunology 1982; 45: 613
   PubMedGoogle Scholar
• Snippe H., Van Houte A. J., Inman J. K., Lizzo E. F., Mechant B. Hapten-specific B-cell blockade of the immune response to a thymus independent-1 antigen produced by concomitant administration of a thymus independent-2 antigen. Immunology 1984; 52: 87
   PubMedGoogle Scholar
• Van Houte A. J., Snippe H. Liposomes as carriers of immunogenic determinants. “Liposome Technology”, G. Gregoriadis. CRL Press Inc. 1984; vol. 2: 125
   Google Scholar
• Zigterman G. J. W. J., Jansze M., Snippe H., Willers J. M. N. Immunomodulating properties of substances to be used in combination with liposomes. Int. Arch. Allergy and Applied Immunol. 1986; 81: 245
   PubMedGoogle Scholar
• Zigterman G. J. W. J., Snippe H., Jansze M., Willers J. M. N. Adjuvant effects of nonionic block polymer surfactants on liposome-induces humoral immune response. J. Immunol. 1987; 138: 220
   PubMedGoogle Scholar
• Wicker L. S., Scher I. X-linked immunodeficiency (Xid) of CBA/N mice. Curr. Topics Microbiol. Immunol. 1986; 124: 87
   PubMed Web of Science ®Google Scholar
• Baker P. J. Regulation of magnitude of antibody response to bacterial polysaccharide antigens by thymus-derived lymphocytes. Infect. Immun. 1990; 58: 3465
   PubMedGoogle Scholar
• Wood C., Kabat E. A. Immunochemical studies of conjugates of isomaltosyl oligosaccharides to lipids. I. Antigenicity of the glycolipids and the production of specific antibodies in rabbits. J. Exp. Med. 1981; 154: 432
   PubMedGoogle Scholar
• Sarkar D. P., Das P. K., Bachhawat B. K., Das M. K. The adjuvant effect of liposomes in eliciting anti-galactosyl antibodies. Immunol. Commun. 1982; 11: 175
   PubMed Web of Science ®Google Scholar
• Snippe H., Van Dam J. E. G., Van Houte A. J., Willers J. M. N., Kamerhng J. P., Vliegenthart J. F. G. Preparation of a semi-synthetic vaccine to infection with Streptococcus pneumoniae type 3. Infect. Immun. 1983; 42: 842–844, 1983
   PubMedGoogle Scholar
• Brade L., Brandenburg K, Kuhn H. M., Kusumoto S., Macher I., Rietschel E. T., Brade H. The immunogenicity and antigenicity of lipid A are influenced by its physicochemical state and environment. Infect. Immun. 1987; 55: 2636
   PubMed Web of Science ®Google Scholar
• Faille C, Michalski J. C., Strecker G., Mackenzie D. W. R., Camus D., Poulain D. Immunoreactivity of neoglycolipids constructed from oligomannosidic residues of the Candida albicans cell wall. Infect. Immun. 1990; 58: 3537
   PubMedGoogle Scholar
• Brodin T., Thurin J., StrOmberg N., Karlsson K. A., Sjogren H. O. Production of oligosaccharide-binding monoclonal antibodies of diverse specificities by immunization with purified tumor-associated glycolipids inserted into liposomes with lipid A. Eur. J. Immunol. 1986; 16: 951
   PubMedGoogle Scholar
• Wachsmann D, Klein J P, Scho Uer M, Ogier J, Ackermans F, Frank R M. Serum and salivary antibody responses in rats orally immunized with Streptococcus mutans carbohydrate protein conjugate associated with liposomes. Infect. Immun. 1986; 52: 408–413
   PubMed Web of Science ®Google Scholar
• Snippe H., Zigterman G. J. W. J., Van Dam J. E. G., Kamerling J. P. Ligosaccharide-haptenated liposomes used as a vaccine to Streptococcus pneumoniae. “Liposomes as drug carriers: trends and progress”, G. Gregoriadis. John Wiley, SussexEngland 1988; 183
   Google Scholar
• Zigterman G. J. W. J., Verheul A. F. M., Snippe H. Liposomes as immunoadjuvants for saccharide antigens. “Drug Delivery volume 2: Liposomes in drug delivery”, G. Gregoriadis, A. T. Florence, H. M. Patel. Gordon and Breach, Harwood 1993; 67, Chapter 5
   Google Scholar
• Svenson S. B., Lindberg A. A. Coupling of acid labile Salmonella specific oligosaccharides to macromolecular carriers. J. Immunol. Methods 1979; 25: 323
   PubMedGoogle Scholar